Pain Management | MyMerci
제안하기
0 / 2000

Pain Management

Unit 5 · Topic 11Pain Management
1.Overview & Pathophysiology

The International Association for the Study of Pain defines pain as an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. Pain is subjective: the client's self-report is the most reliable indicator, and the nurse accepts and acts on it. The absence of grimacing or normal vital signs does not mean the absence of pain.

Physiology: tissue injury activates nociceptors → transduction → transmission along A-delta (sharp, fast) and C (dull, slow) fibers to the spinal cord and brain → perception → modulation by descending pathways and endogenous opioids. The gate control theory explains why rubbing, massage, TENS, and distraction can reduce pain: stimulation of large sensory fibers "closes the gate" to pain signals in the spinal cord.

Classification

TypeFeaturesExample
AcuteSudden, related to injury, expected to resolve with healing; often raises heart rate and BPPostoperative pain, fracture
ChronicPersists beyond normal healing — longer than about 3 months; vital signs usually normal; linked to depression, sleep loss, disabilityLow back pain, arthritis, cancer pain
Nociceptive — somaticWell localized, aching or sharpBone, skin, muscle
Nociceptive — visceralPoorly localized, cramping, referredBowel, bladder, myocardial ischemia
NeuropathicBurning, shooting, tingling, electricDiabetic neuropathy, postherpetic neuralgia
NociplasticAltered pain processing without clear tissue damageFibromyalgia

Duration is the main feature that separates acute from chronic pain.

2.Assessment Findings

Assess pain on admission, regularly, with each new report, before and after every intervention (commonly 15–30 minutes after IV and 30–60 minutes after oral analgesics), and at rest and with movement.

Characteristics (PQRST / OLDCARTS): onset, location, duration, character (burning, stabbing), aggravating and relieving factors, radiation, timing, severity, and effect on function, sleep, and mood. Ask about the client's goal (a tolerable level that allows activity) and cultural beliefs.

Pain rating tools

ToolPopulation
Numeric Rating Scale (NRS 0–10)Alert adults and older children — the standard
Visual Analog Scale10-cm line from "no pain" to "worst pain"
Wong-Baker FACESChildren about 3 years and older; adults with language barriers
FLACC (Face, Legs, Activity, Cry, Consolability)Infants and young children, nonverbal clients
Neonatal tools (NIPS, CRIES, N-PASS)Newborns — facial expression, cry, breathing, limb movement, state of arousal, vital signs
PAINADOlder adults with advanced dementia
CPOT, Behavioral Pain ScaleCritically ill, intubated, or sedated clients

Behavioral signs (grimacing, guarding, restlessness, moaning) are used when self-report is not possible; family input helps. Physiologic changes (tachycardia, hypertension, diaphoresis) occur with acute pain but adapt quickly and are unreliable alone.

Sedation assessment before and after opioids — Pasero Opioid-Induced Sedation Scale (POSS)

LevelDescriptionAction
SSleeping, easy to arouseAcceptable
1Awake and alertAcceptable
2Slightly drowsy, easily arousedAcceptable
3Frequently drowsy, drifts off during conversationUnacceptable — hold or reduce opioid, monitor closely, notify
4Somnolent, minimal or no responseStop opioid, naloxone, call for help

Sedation precedes respiratory depression — check sedation, respiratory rate and depth, and SpO₂ (or capnography).

3.Diagnostics
  • Diagnostic tests look for the cause of pain (imaging, labs) — there is no laboratory test for pain intensity.
  • Screening tools for opioid risk (history of substance use, mental health conditions) and for opioid-induced respiratory depression risk (obstructive sleep apnea, opioid-naive, older age, obesity, lung disease, concurrent sedatives).
  • Prescription drug monitoring program checks before prescribing controlled substances (United States).
4.Medical Management

Principles: multimodal analgesia (combining drugs and methods that work differently) lowers opioid doses and side effects; prevent pain rather than chase it — give scheduled (around-the-clock) doses for continuous pain with breakthrough doses for flares; use the oral route when possible; avoid IM injections (painful, unreliable absorption).

WHO analgesic ladder (for cancer pain): step 1 non-opioid ± adjuvant (mild pain); step 2 weak opioid or low-dose strong opioid ± non-opioid ± adjuvant (moderate pain); step 3 strong opioid ± non-opioid ± adjuvant (severe pain). Non-opioids and adjuvants can be used at every step. Current WHO cancer pain guidance treats the ladder as a flexible guide — clients with severe pain start directly at the level that matches their pain.

Drug safety

Drug classKey safety points
AcetaminophenMaximum 4 g/day in adults (lower, often 2–3 g/day, with liver disease, heavy alcohol use, or low weight); count acetaminophen in combination products; antidote acetylcysteine
NSAIDs (ibuprofen, naproxen, ketorolac, celecoxib)GI bleeding and ulcers, kidney injury, fluid retention, cardiovascular events; avoid in kidney disease, active bleeding, and some heart conditions; avoid from 20 weeks of pregnancy (fetal kidney dysfunction and oligohydramnios; FDA 2020) and in the third trimester (premature closure of the ductus arteriosus) unless specifically prescribed; ketorolac limited to 5 days
Opioids (morphine, hydromorphone, oxycodone, fentanyl)Respiratory depression, sedation, constipation (most common and persistent — start a stimulant laxative regimen), nausea, pruritus, urinary retention, orthostatic hypotension; hold and notify for excessive sedation or a respiratory rate below about 10–12/min or shallow breathing, per policy; fentanyl patches only for opioid-tolerant clients — heat increases absorption
NaloxoneOpioid antagonist for respiratory depression; for clients receiving opioids for pain, give it diluted and titrated to restore breathing rather than full reversal (full reversal causes severe pain and withdrawal) — e.g., 0.4 mg diluted to 10 mL, given 0.04 mg (1 mL) every 1–2 minutes until breathing improves; it is shorter-acting than most opioids — watch for recurrent sedation
Codeine, tramadolUnpredictable metabolism; contraindicated in children under 12 and after tonsillectomy/adenoidectomy in those under 18; not recommended during breastfeeding (ultra-rapid metabolizer risk to the infant); tramadol lowers seizure threshold and can cause serotonin syndrome
MeperidineAvoid — toxic metabolite causes seizures
Adjuvants — gabapentin, pregabalin, duloxetine, amitriptyline, corticosteroids, local anestheticsNeuropathic and bone pain; gabapentinoids add sedation and respiratory depression with opioids; tricyclics are anticholinergic (avoid in older adults)
Patient-controlled analgesia (PCA)Only the client presses the button — PCA by proxy (family or staff) can cause overdose; lockout interval prevents overdose; continuous monitoring (capnography preferred with supplemental oxygen) for high-risk clients

Switching opioids or routes: use an equianalgesic table only as a guide — reduce the calculated dose of the new opioid by about 25–50% for incomplete cross-tolerance and reassess sedation closely. Oral doses are much larger than IV doses (oral morphine is roughly 3 times the IV dose). Hydromorphone is several times more potent than morphine — confusing the two is a known fatal error. Fentanyl patch conversions follow the product's own table.

Tolerance, dependence, and addiction differ: tolerance (needing a higher dose for the same effect) and physical dependence (withdrawal if stopped abruptly) are expected physiologic changes with regular opioid use; opioid use disorder (addiction) is a behavioral disease of compulsive use despite harm. Fear of addiction should not lead to undertreatment of pain.

5.Nursing Interventions
  1. Believe the client's report and assess systematically; document intensity, character, and response.
  2. Respiratory safety with opioids: check sedation (POSS) and respiratory status before each dose and at peak effect; use continuous monitoring for high-risk clients; keep naloxone and a bag-valve mask available.
  3. Treat pain early: give analgesics before pain becomes severe and before painful activities (dressing changes, ambulation, physiotherapy).
  4. Reassess after each intervention and adjust the plan with the provider.
  5. Prevent side effects: bowel regimen with regular opioids; antiemetics; fall precautions; urinary retention check.
  6. Nonpharmacologic measures (combine with drugs, never instead of needed drugs)
    • Physical: cold for acute injury (first 24–48 hours; reduces swelling and pain), heat for muscle spasm and chronic stiffness, massage, positioning, splinting, TENS
    • Cognitive-behavioral: distraction, relaxation breathing, guided imagery, music, meditation, education that reduces fear
    • Infants: sucrose, breastfeeding, skin-to-skin contact, swaddling
    • Limit applications to about 20–30 minutes for heat and 15–20 minutes for cold (see Thermoregulation); protect skin with a barrier; extra caution with impaired sensation or circulation
  7. Chronic pain: set functional goals (walking, sleep, work) rather than zero pain; scheduled analgesia; interdisciplinary care (physical therapy, psychology, pharmacy); screen for depression.
  8. Cancer pain at the end of life: the goal is comfort and quality of life; scheduled opioids with breakthrough doses; sedation that results from adequate symptom relief is acceptable when intended to relieve suffering.
6.Client Education
  • Report pain early and honestly; use the rating scale; state your comfort goal.
  • Take long-acting opioid tablets whole — never crush or chew extended-release forms.
  • Opioids: no alcohol, sedatives, or cannabis without advice; do not drive until you know how they affect you; take a laxative regularly; rise slowly.
  • Store opioids locked and out of reach; dispose of leftovers at take-back sites or as instructed; household members may need naloxone at home.
  • Check labels for hidden acetaminophen and NSAIDs in cold and flu products.
  • Nonpharmacologic strategies to practice at home: relaxation, heat or cold, gentle activity.
7.Complications & Red Flags
ProblemClues and response
Opioid-induced respiratory depressionIncreasing sedation (POSS 3–4), slow shallow breathing, snoring, falling SpO₂ or rising EtCO₂ — stimulate, stop opioid, oxygen, naloxone titrated, call for help
Undertreated painSleep loss, immobility, delayed recovery, chronic pain development
Severe constipation or ileusNo stool for days, distension
NSAID GI bleedingBlack stools, epigastric pain, anemia
Acetaminophen toxicityNausea, right upper quadrant pain, raised liver enzymes
Serotonin syndrome (tramadol with antidepressants)Agitation, fever, clonus
New, sudden, or different painMay signal a complication (compartment syndrome, myocardial infarction, anastomotic leak) — assess, do not simply medicate
8.High-Yield Points
  • Pain is what the client says it is — self-report is the most reliable measure
  • NRS 0–10 for alert adults; FACES for children about 3+; FLACC for young children; neonatal scales for newborns; PAINAD for advanced dementia
  • Duration separates acute from chronic pain (chronic > about 3 months)
  • Sedation precedes respiratory depression; POSS 3 → hold or reduce the opioid
  • Naloxone: dilute and titrate; watch for recurrent sedation
  • Constipation is the most common persistent opioid adverse effect — give laxatives prophylactically
  • PCA: only the client presses the button
  • WHO ladder: step up by pain intensity; non-opioids and adjuvants can be added at every step
  • Acetaminophen maximum 4 g/day (less with liver risk); ketorolac ≤ 5 days
  • Distraction, relaxation, imagery = cognitive-behavioral; NSAIDs are pharmacologic; oxygen is not a pain intervention
  • Chronic pain: preventive scheduled analgesia, functional goals, interdisciplinary care
  • End-of-life pain: goal is comfort and quality of life

Country Notes

United States

  • The CDC 2022 Clinical Practice Guideline for prescribing opioids for pain emphasizes non-opioid therapies where effective, the lowest effective dose of immediate-release opioids for acute pain, reassessment, and offering naloxone when overdose risk is increased.
  • Many states limit initial opioid prescriptions for acute pain; prescription drug monitoring programs are used before prescribing.

Philippines

  • Opioids are regulated dangerous drugs requiring special prescription forms and licenses under national law; access to strong opioids outside larger hospitals can be limited, so plan discharge supplies early for palliative clients.
  • Family members often manage medications at home; teach them sedation warning signs, safe storage, and the importance of the bowel regimen.

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.